Upper Gastrointestinal Bleeding from non-gestational Primary Gastric Choriocarcinoma

Braney Thabiso Modiba, Ranti Kenny Maila, Livhuwani Christina Makhuvha, Mirza Mohamod Zahir Uddin Bhuiyan
Author(s)
1Department of General Surgery, Mankweng Academic Hospital, Faculty of Health Sciences, University of Limpopo, South Africa

Abstract

Background: Upper gastrointestinal bleeding from non-gestational primary gastric choriocarcinoma is extremely rare. Non-gestational primary gastric choriocarcinoma is an aggressive β-human chorionic gonadotropin–producing malignancy and it accounts for less than 1% of all gastric cancers. A 37-year-old woman with primary non-gestational gastric choriocarcinoma with hepatic metastasis presented with unintentional weight loss, gastrointestinal bleeding, abdominal pain, early satiety, and a disproportionately elevated serum β-human chorionic gonadotropin (β-hCG) level of 74,906 IU/L. On clinical examination, a palpable epigastric mass was noted. Initial clinical diagnosis of gastric malignancy was made, and upper gastrointestinal endoscopy revealed a malignant-appearing gastric lesion. Contrast enhanced Computed tomography of the abdomen demonstrated a large ulceroinfiltrative, malignant-looking gastric mucosal lesion at the antrum. Histopathological examination of the endoscopic biopsy specimen confirmed choriocarcinoma. Immunohistochemistry has shown diffused positive tissue staining for B-hCG. Due to the aggressive nature and rapid progression of the disease, the patient died within one month after diagnosis. Early recognition, speedy diagnosis and prompt multidisciplinary management are essential.

Keywords: Non-gestational primary gastric choriocarcinoma, β-human chorionic gonadotropin (β-hCG), gastrointestinal bleeding.

Outline